Drug Shortage Report for TRIESENCE
Report ID | 65471 |
Drug Identification Number | 02368676 |
Brand name | TRIESENCE |
Common or Proper name | TRIESENCE 1ML SUSP |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TRIAMCINOLONE ACETONIDE |
Strength(s) | 40MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAVITREAL |
Packaging size | 1ML |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-11-02 |
Actual start date | |
Estimated end date | 2018-11-21 |
Actual end date | 2018-11-06 |
Shortage status | Resolved |
Updated date | 2018-11-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-23 | English | Compare |
v2 | 2018-10-23 | French | Compare |
v3 | 2018-10-26 | English | Compare |
v4 | 2018-10-26 | English | Compare |
v5 | 2018-10-26 | French | Compare |
v6 | 2018-10-31 | English | Compare |
v7 | 2018-10-31 | English | Compare |
v8 | 2018-10-31 | French | Compare |
v9 | 2018-11-03 | English | Compare |
v10 | 2018-11-07 | English | Compare |
v11 | 2018-11-07 | French | Compare |
Showing 1 to 11 of 11